|
|
|
 |
|
|
|
|
|
|
伝・最澄『法華肝要略注秀句集』の『法華経』解釈：日蓮由来の教義を中心に=The View of the Lotus Sūtra in the Hokke kanyō ryakuchū shukushū Attributed to Saichō: The Doctrines Derived from Nichiren |
|
|
|
| Author |
岡田文弘 (著)=Okada, Fumihiro (au.)
|
|---|
| Source |
印度學佛教學研究 =Journal of Indian and Buddhist Studies=Indogaku Bukkyōgaku Kenkyū
|
|---|
| Volume | v.70 n.1 (總號=n.155) |
|---|
| Date | 2021.12.20 |
|---|
| Pages | 253 - 258 |
|---|
| Publisher | 日本印度学仏教学会 |
|---|
| Publisher Url |
http://www.jaibs.jp/
|
|---|
| Location | 東京, 日本 [Tokyo, Japan] |
|---|
| Content type | 期刊論文=Journal Article |
|---|
| Language | 日文=Japanese |
|---|
| Keyword | 最澄; 『法華肝要略注秀句集』; 日蓮; 『法華伝記』 |
|---|
| Abstract | This paper discusses the doctrines derived from Nichiren in the Hokke kanyō ryakuchū shukushū 法華肝要略注秀句集, a pseudepigraphic work attributed to Saichō.
The Hokke kanyō ryakuchū shukushū justifies Nichiren’s idea, found in his Kaimokushō 開目抄, that the “Anrakugyō-hon” 安楽行品, chapter 14 of the Lotus Sūtra, is not considered appropriate for the Latter Day of the Dharma, and it did so using wording similar to that in the Kaimokushō, emphasizing the significance of the Bodhisattvas who rose out of the earth.
Furthermore, the Hokke kanyō ryakuchū shukushū associates Nichirens’ idea in his Kanjin honzonshō 観心本尊抄 that the title of the Lotus Sūtra is considered as “good medicine” with the statue of Bhaiṣajyaguru made by Saichō, thereby making Nichiren the legitimate successor to Saichō.
Finally, the Hokke kanyō ryakuchū shukushū cites not only doctrinal literature but also folk-tales, such as the Fahua zhuanji 法華伝記compiled by Sengxiang 僧詳, in order to recommend chanting the title of the Lotus Sūtra. |
|---|
| Table of contents | 一 はじめに 253
二 安楽行品をめぐって——『開目抄』との関連—— 253
三 「是好良薬」と薬師本尊——『観心本尊抄』との関連—— 254
四 唱題の文証——僧祥『法華伝記』との関連—— 255
五 まとめ 256 |
|---|
| ISSN | 00194344 (P); 18840051 (E) |
|---|
| DOI | https://doi.org/10.4259/ibk.70.1_253 |
|---|
| Hits | 42 |
|---|
| Created date | 2023.01.05 |
|---|
| Modified date | 2023.01.05 |
|---|
 |
Best viewed with Chrome, Firefox, Safari(Mac) but not supported IE
|
|
|
